Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/1995
03/09/1995CA2170777A1 Epiligrin, an epithelial ligand for integrins
03/09/1995CA2170751A1 Neuron regulatory factor for promoting neuron survival
03/09/1995CA2170726A1 Bacterial exported proteins and acellular vaccines based thereon
03/09/1995CA2170393A1 Cloning of a member of the serine-threonine-kinase family
03/09/1995CA2170390A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen
03/09/1995CA2169951A1 Monoclonal antibody that recognizes interstitial cell surface antigen
03/09/1995CA2169950A1 Monoclonal antibody that induces apoptosis
03/09/1995CA2168565A1 T cell epitopes of ryegrass pollen allergen
03/09/1995CA2148268A1 Method for specific immunoassay of human plasmatic glutathione peroxidase
03/09/1995CA2118990A1 Catalytic antibodies hydrolyzing acylated carbohydrates with a regio-and stereoselective manner
03/08/1995EP0641801A2 Catalytic antibodies hydrolyzing acylated carbohydrates with a region- and stereoselective manner
03/08/1995EP0641568A1 Chlamydia antigen, process for its manufacture and its use
03/08/1995EP0641439A1 Reagents and methods for the quantification of imipramine or desipramine in biological fluids
03/08/1995EP0641385A1 Development of dna probes and immunological reagents of human tumor associated antigens
03/08/1995EP0641220A1 Methods and agents for modulating immune response, and uses thereof
03/08/1995EP0641218A1 Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality
03/08/1995EP0500641B1 Control of milk secretion
03/07/1995US5395929 Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor
03/07/1995US5395760 Isolated dna sequence encoding selected amino acid sequences
03/07/1995US5395750 Constructing a plurality of synthetic genes, expressing proteins encoded by genes in a microorganism and contacting proteins with antigen to obtain antibody binding to the antigen
03/02/1995WO1995006249A1 Marking of products to establish identity and source
03/02/1995WO1995006247A1 Natural killer cell-specific antigen and antibodies that identify the same
03/02/1995WO1995006131A1 A method for the assay, prophylaxis and/or treatment of human disease conditions
03/02/1995WO1995006129A2 Transfection process
03/02/1995WO1995006123A1 Detection and prevention of mycoplasma hominis infection
03/02/1995WO1995006119A1 Recombinant humanized anti-human immunodeficiency virus antibody
03/02/1995WO1995006118A1 Expression control sequences of the p-selectin gene
03/02/1995WO1995006116A1 Mammalian stromal cell proteins and dna sequences coding therefor
03/02/1995WO1995006067A1 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer
03/02/1995WO1995006066A1 Antibodies specific for cystic fibrosis transmembrane conductance regulator and uses therefor
03/02/1995WO1995006065A1 Cytokines that bind the cell surface receptor hek
03/02/1995WO1995006062A1 Novel proteins isolated from nerve cells, dna sequences encoding same and usages thereof
03/02/1995WO1995006055A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors
03/02/1995WO1995005853A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
03/02/1995WO1995005810A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production
03/02/1995WO1995001437A3 Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis
03/02/1995WO1994029456A3 Herpes simplex virus type-2 protease
03/02/1995WO1994025601A3 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
03/02/1995DE4321944A1 Method for the diagnosis and analysis of colon carcinomas
03/02/1995CA2623540A1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies
03/02/1995CA2170352A1 Natural killer cell-specific antigen and antibodies that identify the same
03/02/1995CA2169941A1 Expression control sequences of the p-selectin gene
03/02/1995CA2169851A1 Cytokines that bind the cell surface receptor hek
03/02/1995CA2169850A1 Marking of products to establish identity and source
03/02/1995CA2169828A1 Transfection process
03/02/1995CA2169755A1 Detection and prevention of mycoplasma hominis infection
03/02/1995CA2169748A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors
03/02/1995CA2169210A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production
03/01/1995EP0640690A1 Monoclonal antibodies specific for 5-dihydrotestosterone
03/01/1995EP0640621A2 Anti-thrombin monoclonal antibody
03/01/1995EP0640620A2 Methods and reagents for inhibiting cholesterol absorption in humans mediated by pancreatic esterase receptor protein
03/01/1995EP0640143A1 Senescent cell derived inhibitors of dna synthesis
03/01/1995EP0640133A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
03/01/1995EP0640131A1 Genetically engineered antibodies
03/01/1995EP0640130A1 Chimeric multivalent protein analogues and methods of use thereof
03/01/1995EP0640129A1 Inhibition of cell adhesion protein-carbohydrate interactions
03/01/1995EP0640102A1 Activation-state-specific phosphoprotein immunodetection
03/01/1995EP0640100A1 Modulation of thrombospondin-cd36 interactions
03/01/1995EP0640098A1 Canine coronavirus s gene and uses therefor
03/01/1995EP0640094A1 Recombinant production of immunoglobulin-like domains in prokaryotic cells
03/01/1995EP0639977A1 Lipid-a analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities
03/01/1995EP0600018A4 Hepatitis c assay utilizing recombinant antigens to c-100 region.
02/1995
02/28/1995US5393891 Useful as standards in testing for presence of quinoline carboxylic acids
02/28/1995US5393523 Administering to protect against malaria
02/26/1995CA2130386A1 Monoclonal antibodies specific for 5-dihydrotestosterone
02/23/1995WO1995005600A1 Methods of detecting and combating disorders of the central nervous system
02/23/1995WO1995005469A1 Human erythropoietin receptor fragment and antibodies thereto
02/23/1995WO1995005468A1 Binding molecules containing at least an immunoglobulin constant domain with modified allotypic determinant
02/23/1995WO1995005463A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells
02/23/1995WO1995005399A1 Design and synthesis of bispecific reagents: use of double-stranded dnas as chemically and spatially defined cross-linkers
02/23/1995WO1995005397A1 Composition and methods using nitroxides to avoid oxygen toxicity
02/23/1995WO1995005392A1 Novel proteins which bind to retinoblastoma protein and their encoding dna sequences
02/23/1995WO1995005196A1 Antibody-based treatment of hiv infection
02/23/1995WO1995005191A1 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF-β ACTIVITY
02/23/1995WO1995005189A1 Class i mhc modulation of surface receptor activity
02/23/1995DE4407538C1 Binding reagent for cell surface protein and effector cell
02/23/1995DE4320677A1 Synthetic peptides for neutralising the infectiosity of the AIDS VIRUS (HIV)
02/23/1995CA2169459A1 Novel proteins which bind to retinoblastoma protein and their encoding dna sequences
02/23/1995CA2169370A1 Antibody-based treatment of hiv infection
02/23/1995CA2169360A1 Methods and compositions for stimulating and inhibiting tgf-.beta. activity
02/23/1995CA2169285A1 Class i mhc modulation of surface receptor activity
02/23/1995CA2169273A1 Methods of detecting and combating disorders of the central nervous system
02/23/1995CA2169178A1 Composition and methods using nitroxides to avoid oxygen toxicity
02/22/1995EP0639225A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
02/22/1995EP0639224A1 Lectin domain variants of selectin
02/22/1995EP0639111A1 Adsorption matrices
02/22/1995EP0639083A1 Complexing agents and targeting immunoreagents
02/21/1995US5391714 Polymorphism of human platelet membrane glycoprotein IIIA and diagnostic applications thereof
02/21/1995US5391704 A labeled polypeptides used to detect and determine anti-immunoglobulins autoantibodies in autoimmune diseases
02/21/1995US5391481 Medical diagnosis for disorders associated with elevated levels of very late antigens-1
02/16/1995WO1995004822A1 Human calcium channel compositions and methods using them
02/16/1995WO1995004819A1 NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF-β FAMILY
02/16/1995WO1995004758A1 Monoclonal antibodies to thymidine kinase isozymes
02/16/1995WO1995004757A1 Use of monoclonal antibodies for determining sensitivity to acetylizable drugs
02/16/1995WO1995004755A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments
02/16/1995WO1995004750A1 Tick derived protease inhibitor
02/16/1995WO1995004548A1 Prostatic cancer vaccine
02/16/1995WO1995004547A1 POLYPEPTIDES CODED BY EXON v5 OF THE CD44 GENE AS TARGETS FOR IMMUNOTHERAPY AND IMMUNOSCINTIGRAPHY OF TUMOURS
02/16/1995WO1994029451A3 Humanised antibodies
02/16/1995DE4434320A1 Process for the preparation and the use of monoclonal antibodies against X or Y chromosome-containing sperm for separating spermatozoa